Related Experiment Video
Updated: Jun 29, 2025

05:17
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
8.6K
Exploiting the metabolic vulnerability of circulating tumour cells
Munise Merteroglu1, Massimo M Santoro1
1Department of Biology, University of Padua, Padua, Italy.
Trends in Cancer
|April 5, 2024
Summary
Metastasis drives cancer severity. Circulating tumor cells (CTCs) adapt metabolic pathways to survive bloodstream stress and colonize secondary sites, offering new therapeutic targets.
Area of Science:
- Oncology
- Cancer Biology
- Metabolism
Background:
- Metastasis significantly contributes to cancer morbidity and mortality.
- Circulating tumor cells (CTCs) are precursors to metastasis but face hostile conditions in the bloodstream.
- Survival and colonization of CTCs depend on specific environmental adaptations.
Purpose of the Study:
- To review recent advances in understanding circulating tumor cell (CTC) biology.
- To highlight discoveries in metabolic pathway adaptations during CTC selection.
- To underscore the importance of understanding CTC traits for cancer prognosis and therapy.
Main Methods:
- Review of recent literature on CTC isolation and 'omics technologies.
- Analysis of findings related to CTC survival mechanisms.
- Synthesis of knowledge on metabolic adaptations in CTCs.
Main Results:
- CTCs must acquire specific physical, metabolic, and oxidative stress protection states to survive.
- High-resolution 'omics technologies are identifying key metabolic pathways involved in CTC selection.
- Understanding these adaptations is crucial for developing targeted cancer strategies.
Conclusions:
- Circulating tumor cell (CTC) biology and metabolic adaptations are critical areas for cancer research.
- Identifying mechanisms of acquired resistance and vulnerability in CTCs can lead to improved prognostic and therapeutic strategies.
- Further research into CTC metabolism holds promise for advancing cancer treatment.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

